0001477932-21-003575.txt : 20210525
0001477932-21-003575.hdr.sgml : 20210525
20210525060140
ACCESSION NUMBER: 0001477932-21-003575
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161117
FILED AS OF DATE: 20210525
DATE AS OF CHANGE: 20210525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davidson Robert Steven
CENTRAL INDEX KEY: 0001412747
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55908
FILM NUMBER: 21957267
MAIL ADDRESS:
STREET 1: 7633 E. 63RD PLACE, #220
CITY: TULSA
STATE: OK
ZIP: 74133
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp.
CENTRAL INDEX KEY: 0001643301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371765151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805-824-0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
FORMER COMPANY:
FORMER CONFORMED NAME: Makkanotti Group Corp.
DATE OF NAME CHANGE: 20150526
4
1
form4.xml
FORM 4
X0306
4
2016-11-17-05:00
false
0001643301
Cure Pharmaceutical Holding Corp.
CURR
0001412747
Davidson Robert Steven
1620 BEACON PLACE
OXNARD
CA
93022
true
true
false
false
Chief Executive Officer
Common Stock
2018-10-10-05:00
4
G
false
25000
0.00
D
524756
D
Common Stock
2019-07-01-05:00
4
A
false
31250
0.00
A
556006
D
Common Stock
2021-05-24-05:00
4
P
false
6443
0.689
A
562449
D
Stock Option
0.74
2016-11-07-05:00
4
A
false
354000
0.00
A
2028-04-06-05:00
Common Stock
354000
354000
D
Stock Option
0.61
2018-05-07-05:00
4
A
false
68750
0.00
A
2028-05-07-05:00
Common Stock
68750
68750
D
Stock Option
3.40
2019-04-11-05:00
4
A
false
225000
0.00
A
2029-04-11-05:00
Common Stock
225000
225000
D
The reporting person transferred 25,000 shares of common stock to his son as a bona-fide gift. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
Represents shares of common stock received upon vesting of a restricted stock award. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.68422 to $0.69350. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 3 decimal points.
The option becomes exercisable on the basis determined by the equity incentive plan with 6.25% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
/s/ Robert Davidson
2021-05-25-05:00